NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 15 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 6.20% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 4.09% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.65% |
| CNC | Centene Corp | Healthcare | Healthcare Plans | 3.49% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 3.47% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.35% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.32% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 3.10% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.08% |
| BRKR | Bruker Corporation | Healthcare | Medical Devices | 3.01% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 2.82% |
| INSP | Inspire Medical Systems Inc | Healthcare | Medical Devices | 2.77% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.58% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 2.55% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 2.41% |